LGND

Ligand Pharmaceuticals Incorporated News Headlines

$53.97
*  
0.16
0.3%
Get LGND Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading LGND now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    LGND After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Can Epizyme (EPZM) Surprise This Earnings Season? - Analyst Blog
10/24/2014 3:48:00 PM - Zacks.com


Ligand (LGND) Shares March Higher, Can It Continue? - Tale of the Tape
10/24/2014 9:27:05 AM - Zacks.com


Why Earnings Season Could Be Great for Ligand (LGND) - Tale of the Tape
10/24/2014 8:36:00 AM - Zacks.com


Omeros Falls as Enrollment for OMS824 Study is Suspended - Analyst Blog
10/23/2014 4:10:00 PM - Zacks.com


Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog
10/22/2014 5:54:00 PM - Zacks.com


Will Bristol-Myers (BMY) Disappoint This Earnings Season? - Analyst Blog
10/22/2014 5:00:00 PM - Zacks.com


Will Agenus (AGEN) Incur Wider-than-Expected Q3 Loss? - Analyst Blog
10/22/2014 4:30:00 PM - Zacks.com


Amgen Gains as Third Point Suggests Split - Analyst Blog
10/22/2014 1:50:00 PM - Zacks.com


Biogen's Q3 Earnings Top Estimates, View Raised Again - Analyst Blog
10/22/2014 1:10:00 PM - Zacks.com


Actelion Misses Q3 Earnings Expectation, Ups 2014 Guidance - Analyst Blog
10/22/2014 11:40:00 AM - Zacks.com


Pacific Biosciences to Incur Narrower-than-Expected Q3 Loss - Analyst Blog
10/21/2014 5:50:00 PM - Zacks.com


Will BioMarin (BMRN) Disappoint This Earnings Season? - Analyst Blog
10/21/2014 5:30:00 PM - Zacks.com


Will Alexion (ALXN) Earnings Suffer Due to Higher Costs? - Analyst Blog
10/21/2014 5:05:00 PM - Zacks.com


Celgene (CELG) Q3 Earnings to Be Overrun by Expenses? - Analyst Blog
10/21/2014 4:50:00 PM - Zacks.com


Why Ligand Pharmaceuticals (LGND) Isn't Done Growing Earnings Yet - Tale of the Tape
10/21/2014 8:48:00 AM - Zacks.com


Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog
10/20/2014 6:15:00 PM - Zacks.com


Will Biogen Idec (BIIB) Pull a Surprise this Earnings Season? - Analyst Blog
10/20/2014 4:45:00 PM - Zacks.com


Will Abbott Labs (ABT) Miss on Earnings This Quarter? - Analyst Blog
10/20/2014 4:35:00 PM - Zacks.com


Will Sangamo (SGMO) Incur Wider-than-Expected Q3 Loss? - Analyst Blog
10/20/2014 12:50:00 PM - Zacks.com


Fr. Emmanuel Lemelson On Recent Sell-Off In Equity Markets, Amvona Fund's Long And Short Positions
10/18/2014 10:12:00 AM - Seeking Alpha


Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog
10/17/2014 5:00:00 PM - Zacks.com


Intra-Cellular Therapies Reveals Top-line Data on ITI-007 - Analyst Blog
10/16/2014 5:50:00 PM - Zacks.com


Tekmira Presents Data on Hepatitis B Candidate TKM-HBV - Analyst Blog
10/16/2014 5:30:00 PM - Zacks.com


Alexion (ALXN) Seeks Japanese Approval for Asfotase Alfa - Analyst Blog
10/16/2014 4:30:00 PM - Zacks.com


Can Illumina (ILMN) Keep the Earnings Streak Alive in Q3? - Analyst Blog
10/16/2014 1:50:00 PM - Zacks.com